Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0000899243-20-030866

Chairman sold 39,391 shares at an average $91.79 ($3,615,680)

  • Chairman acquired 39,391 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

El-Hibri Fuad · Chairman

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-09 Exercise or conversion : show line 1 in the form +20,000 $26.45 $529,000 1,143,988 D
2020-11-09 Sale : show line 2 in the form −20,000 $95.26 $1,905,200 1,123,988 D
2020-11-10 Exercise or conversion : show line 3 in the form +19,391 $26.45 $512,892 1,143,379 D
2020-11-10 Sale : show line 4 in the form −19,391 $88.21 $1,710,480 1,123,988 D
Open-market sales · 39,391 sh · avg $91.79 · $3,615,680

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-11-09 Exercise or conversion : show line 5 in the form Stock Options (Right to Buy) −20,000 19,391 D
2020-11-10 Exercise or conversion : show line 6 in the form Stock Options (Right to Buy) −19,391 0 D
Loading xslF345X03/doc4.xml…